SNY
Sanofi·NASDAQ
--
--(--)
--
--(--)
SNY fundamentals
Sanofi (SNY) Revenue Breakdown: Q4 2025 Business & Regional Performance
Sanofi (SNY) reported total revenue of 14.32B USD in Q4 2025, with its core business segment Biopharma contributing 92.61%. Regionally, United States remained the largest market, accounting for 51.34% of total revenue. Explore Sanofi's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Sanofi (SNY) reported total revenue of 14.32B USD in Q4 2025, with its core business segment Biopharma contributing 92.61%. Regionally, United States remained the largest market, accounting for 51.34% of total revenue. Explore Sanofi's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What is the market's earnings forecast for Sanofi next quarter?What is the revenue and EPS growth rate for Sanofi year over year?What is Sanofi's latest dividend and current dividend yield?What is Sanofi's gross profit margin?What were the key takeaways from Sanofi's earnings call?What does Sanofi do and what are its main business segments?Did Sanofi beat or miss consensus estimates last quarter?What guidance did Sanofi's management provide for the next earnings period?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
